EVH
Evolent Health Inc
NYSE: EVH · HEALTHCARE · HEALTH INFORMATION SERVICES
$3.75
-1.06% today
Updated 2026-04-30
Market cap
$349.43M
P/E ratio
—
P/S ratio
0.19x
EPS (TTM)
$-5.07
Dividend yield
—
52W range
$2 – $12
Volume
3.2M
Evolent Health Inc (EVH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.75
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.9B | $1.4B | $2.0B | $2.6B | $1.9B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -28.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.